Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Sell
2,900
-1,100
-28% -$104K 0.02% 102
2025
Q4
$381K Sell
4,000
-144,400
-97% -$17M 0.03% 95
2025
Q3
$19.4M Sell
148,400
-2,400
-2% -$290K 1.61% 21
2025
Q2
$17M Buy
150,800
+34,600
+30% +$3.59M 1.41% 30
2025
Q1
$10.8M Sell
116,200
-970
-0.8% -$98.4K 0.93% 56
2024
Q4
$12.5M Hold
117,170
1.08% 46
2024
Q3
$12.1M Sell
117,170
-81,100
-41% -$7.62M 0.93% 55
2024
Q2
$17.5M Buy
198,270
+38,800
+24% +$3.54M 1.41% 32
2024
Q1
$15.6M Buy
159,470
+700
+0.4% +$63.3K 0.74% 47
2023
Q4
$14.7M Sell
158,770
-138,300
-47% -$11.7M 1.02% 51
2023
Q3
$24.7M Buy
297,070
+179,570
+153% +$15.5M 1.69% 9
2023
Q2
$9.95M Buy
+117,500
New +$9.63M 0.7% 68

Other funds holding ACM

Payden & Rygel's ACM Position: Q1 2026 in Review

Payden & Rygel reduced its Aecom (ACM) stake by 28% in Q1 2026, selling an estimated $104K and leaving 2,900 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #102.

Payden & Rygel first reported a position in ACM in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.7M in Q3 2023. 618 funds tracked by Wall St. Rank hold ACM as of Q1 2026.

  • Payden & Rygel held 2,900 shares of Aecom worth $246K as of Q1 2026.
  • Payden & Rygel sold 1,100 Aecom shares in Q1 2026, an estimated $104K.
  • Aecom made up 0.02% of Payden & Rygel's portfolio in Q1 2026, its #102 holding.
  • Payden & Rygel first reported a position in Aecom in Q2 2023 and has held it in 12 quarters since.
  • Payden & Rygel's Aecom position peaked at $24.7M in Q3 2023.
  • 618 funds tracked by Wall St. Rank held Aecom as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.